Evaluation of dosage adjustment in patients with renal impairment

Internal Medicine Journal

Volumn 33, Issue 1-2, 2003, Pages 10-13

  Pillans, Peter I ^a   Landsberg, P G ^a   Fleming, A M ^a   Fanning, M ^a   Sturtevant, J M ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Adjustment; Dosage; Drug; Renal impairment

Indexed keywords

ALLOPURINOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CIPROFLOXACIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG METABOLITE; ENALAPRIL; GLIBENCLAMIDE; LISINOPRIL; METFORMIN; OXIPURINOL; PERINDOPRIL; QUINAPRIL; RAMIPRIL; SOTALOL;

ADULT; AGE; AGED; ARTICLE; CREATININE CLEARANCE; DOSE CALCULATION; DOSE RESPONSE; DRUG MEGADOSE; DRUG OVERDOSE; EOSINOPHILIA; FEMALE; FEVER; HEPATITIS; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY FUNCTION; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RASH; RISK FACTOR; SIDE EFFECT; TORSADE DES POINTES; URINARY EXCRETION;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY FAILURE; MALE; MEDICAL AUDIT; MEDICATION ERRORS; METABOLIC CLEARANCE RATE; METFORMIN; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 0037283632     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2003.00330.x     Document Type: Article

References (16)

1. Matzke GR, Frye RF. Drug administration in patients with renal insufficiency. Drug Safety 1997; 16: 205-31.
2. Thomson NM. Drugs and the kidney in the elderly. Med J Aust 1995; 162: 543-7.
3. St Peter WL, Halstenson CE. Pharmacologic approach in patients with renal failure. In: Chernow B, ed. The Pharmacological Approach to the Critically Ill Patient. Baltimore: William and Wilkins; 1994; 41-79.
4. Brater DC. Drug Use in Renal Disease. Balgowlah: ADIS Health Science Press; 1993.
5. Bennett WM. Guide to drug dosage in renal failure. In: Speight TM, Holford NHG eds. Avery's Drug Treatment. Auckland: ADIS International; 1997; 1725-56.
6. Gambertogia JG, Aweeka FT, Blythe WB. Special considerations for prescribing drugs for patients with renal failure. In: Schrier RW, Gottschalk CW, eds. Diseases of the Kidney. Boston: Little Brown and Co; 1993; 3235-63.
7. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 13-41.
8. Anon. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd; 2001.
9. Anon. British National Formulary. Wallingford: The Pharmaceutical Press; 2001.
10. McClintock AD, Egan AJ, Woods DJ, Pillans PI. A survey of allopurinol dosage prescribing. Aust N Z Med J 1995; 108: 346-7.
11. Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993; 27: 337-43.
12. Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984; 76: 47-56.
13. Emmerson BT, Gordon RB, Cross M, Thomson DB. Plasma oxypurinol concentration during allopurinol therapy. Br J Rheumatol 1987; 26: 445-9.
14. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gibbi A, Fleming GA. Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 1998; 338: 265-6.
15. Anon. Metformin and lactic acidosis: a reminder. Australian Adverse Drug Reactions Bulletin 2001; 20: 2-3.
16. Basta MN, Leitch JW, Fletcher PJ. Sotalol proarrhythmia: a report of five cases and an audit of the use of sotalol in a teaching hospital. Aust NZ J Med 1996; 26: 167-70.